Aladdin Healthcare Technologies SE Logo

Aladdin Healthcare Technologies SE

Develops AI for drug discovery and diagnostics targeting age-related diseases.

NMI | BE

Overview

Corporate Details

ISIN(s):
DE000A12ULL2
LEI:
391200M0N1PWTP19RE15
Country:
Germany
Address:
Unter den Linden 10, 10117 Berlin
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Aladdin Healthcare Technologies SE is a developer of artificial intelligence (AI) solutions for the healthcare sector, specializing in diagnostics and drug discovery for age-related diseases. The company leverages its proprietary AI and deep learning technologies across three core platforms: Drug Discovery, Biomedical Knowledge Graphs, and Disease Diagnosis. Its applications aim to accelerate the discovery of novel therapeutics and enhance disease detection through advanced analysis of medical data, including image processing. Key areas of focus include developing new compounds for conditions like Alzheimer's and creating automated diagnostic tools for medical imaging.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-02 16:41
Legal Proceedings Report
Aladdin Healthcare Technologies SE: Antrag auf Eroffnung eines Insolvenzverfahr…
German 4.8 KB
2022-08-15 13:30
Legal Proceedings Report
Aladdin Healthcare Technologies SE: Notice of fine by BaFin in the total amoun…
English 5.1 KB
2022-02-02 16:46
Declaration of Voting Results & Voting Rights Announcements
English 15.1 KB
2022-02-02 15:25
Director's Dealing
DGAP-DD: Aladdin Healthcare Technologies SE english
English 7.7 KB
2022-02-01 17:01
Declaration of Voting Results & Voting Rights Announcements
English 14.2 KB
2022-02-01 15:54
Declaration of Voting Results & Voting Rights Announcements
English 14.1 KB
2021-12-03 10:51
Declaration of Voting Results & Voting Rights Announcements
English 14.2 KB
2021-11-24 09:00
Regulatory News Service
Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA
English 8.7 KB
2021-11-03 09:00
Report Publication Announcement
English 3.5 KB
2021-11-02 16:51
Declaration of Voting Results & Voting Rights Announcements
English 15.2 KB
2021-11-02 16:47
Declaration of Voting Results & Voting Rights Announcements
English 13.9 KB
2021-09-28 11:35
Report Publication Announcement
English 3.9 KB
2021-09-23 18:41
Declaration of Voting Results & Voting Rights Announcements
English 15.1 KB
2021-09-20 19:34
Director's Dealing
DGAP-DD: Aladdin Healthcare Technologies SE english
English 7.6 KB
2021-07-14 08:36
Regulatory News Service
Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis
English 10.2 KB

Automate Your Workflow. Get a real-time feed of all Aladdin Healthcare Technologies SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Aladdin Healthcare Technologies SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-02-02 Menpes-Smith, Mr Wade Board Other None 211,425.00 EUR
2021-09-21 Continental Aktiengesellschaft Close relation Sell None 243,288.00 EUR
2021-09-20 Smith, Wade Board Other None 211,425.00 EUR

Peer Companies

Company Country Ticker View
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD
Pharnext Logo France ALPHA
PHYSIOMICS PLC Logo
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom PYC
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom N/A
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC Logo
R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.
United Kingdom QBT

Talk to a Data Expert

Have a question? We'll get back to you promptly.